La vendita allo scoperto per Viridian Therapeutics dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Viridian Therapeutics. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Viridian Therapeutics (NASDAQ:VRDN) Azioni, Report sulle vendite allo scoperto

Viridian Therapeutics

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics Inc

<p>TD Cowen  analyst John Kernan   maintains Burlington Stores (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) with a Buy and raises the price target from $288 to $334.</p>


News

Price Target

Analyst Ratings

BURL

TD Cowen Maintains Buy on Burlington Stores, Raises Price Target to $334

<p>With India positioning itself as a significant player in the global semiconductor landscape, <strong>Advanced Micro Devices Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) <a href="https://www.benzinga.com/topic/india">is doubling its investments</a>. </p>
<p>The chipmaking giant views India as a burgeoning market and an essential development hub for innovation and technology growth.</p>
<p>Speaking <a href="https://www.cnbctv18.com/business/amd-ceo-lisa-su-india-essential-development-hub-19513318.htm" target="_blank" rel="noreferrer noopener">to</a> CNBC, AMD CEO <strong>Lisa Su</strong> highlighted India&#8217;s strategic importance, calling it integral to the company&#8217;s global operations. The Bengaluru design center, AMD&#8217;s largest R&amp;D facility outside the U.S., employs over 8,000 people. It also plays a crucial role in hardware, software, and systems development.</p>
<p>AMD has pledged $400 million in investments in India through 2028. The goal is to bolster its infrastructure and foster a comprehensive semiconductor ecosystem.</p>
<p>Su <a href="https://economictimes.indiatimes.com/tech/technology/every-amd-product-goes-via-india-team-chair-ceo-lisa-su/articleshow/115540041.cms?from=mdr" target="_blank" rel="noreferrer noopener">told</a> the Economic Times that AMD is collaborating with the Indian government to develop two supercomputers focused on weather forecasting. She described these projects as examples of the suitable investments being made in the country. </p>
<p>Additionally, Su highlighted the potential of artificial intelligence (AI) as the most transformative technology in five decades, with AMD&#8217;s products aiming to make AI more efficient and accessible over time.</p>
<p>Su emphasized that India plays a pivotal role in AMD&#8217;s global portfolio. Every product line passes through the country&#8217;s design center. These initiatives align with India&#8217;s ambitions to become a leader in semiconductor manufacturing and artificial intelligence.</p>
<p>Establishing such ecosystems requires time, Su says. She&#8217;s also optimistic about India&#8217;s progress, pointing to its success in attracting global investments and developing critical infrastructure.</p>
<p>AMD plans to <a target="_blank" href="https://www.benzinga.com/24/11/41961230/amd-plans-to-cut-4-of-workforce-amid-strategic-shift-toward-ai-chip-development-to-rival-jensen-huang-led-nvidias-dominance-report" rel="noreferrer noopener">cut around 1,000 jobs</a>, accounting for 4% of its global workforce, as part of its resource realignment strategy.</p>
<p>The chip designer aims to sharpen its focus on competing with <strong>Nvidia Corp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).</p>
<p>The chipmaker has been heavily investing in developing AI chips, which are highly sought after by significant hyperscalers such as <strong>Microsoft Corp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>). These high-performance chips come with a substantial price tag and are crucial in expanding AMD&#8217;s presence in the AI market.</p>
<p><strong>Price Action:</strong> AMD stock is up 1.85% at $140.91 premarket at last check Monday.</p>
<p><strong>Now Read:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/general/biotech/24/11/42164927/cassava-sciences-controversial-alzheimers-drug-fails-to-hit-primary-goal-in-pivotal-study-halts-late-stage-studies">Cassava Sciences Alzheimer&#8217;s Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Asia

Government

Tech

Media

MSFT

NVDA

AMD Boosts India Presence With $400 Million Investment, Supercomputers For Weather Forecasting

Trading Ideas

QMCO

Quantum Corp Shares Halted On Circuit Breaker To The Upside, Stock Now Up 122.1%

<p><strong>Anglo American</strong> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AAUKF#OTC">AAUKF</a>) has agreed to sell its Australian steelmaking coal portfolio to <strong>Peabody Energy</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTU#NYSE">BTU</a>) for up to $3.8 billion. The sale marks another step toward future-facing commodities, following the $1.1 billion sale of its stake in the <strong>Jellinbah Group</strong> <a href="https://www.benzinga.com/news/large-cap/24/11/41739206/anglo-american-offloads-1-1-billion-coal-stake-proceeds-with-restructuring">earlier this month</a>.</p>
<p>&#8220;We're pleased to acquire these world-class assets from Anglo American, a company that shares our strong values of safety, sustainability, and social license to operate,&#8221; <a href="https://www.angloamerican.com/media/press-releases/2024/25-11-2024">said</a> Peabody CEO <strong>Jim Grech.</strong> &#8220;We look forward to integrating these assets, teaming up with their highly skilled workforce, and aligning with our new mine joint venture partners to create long-term value.&#8221;</p>
<p>This coal portfolio includes an 88% stake in the <strong>Moranbah North JV</strong>, a 70% interest in the <strong>Capcoal JV</strong>, and several other major interests, such as the <strong>Dawson</strong> and <strong>Roper Creek JVs</strong>. These assets are critical producers of metallurgical coal, essential for steelmaking, and should be meaningful contributors to Peabody&#8217;s operations.</p>
<p>Per the deal's terms, Anglo American will receive an upfront cash payment of $2.05 billion, deferred cash payments totaling $725 million, a price-linked earnout of up to $550 million, and $450 million contingent on the reopening of the <strong>Grosvenor</strong> mine. The deal will close by Q3 2025, pending regulatory approvals.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/news/global/24/11/42156160/palantir-price-target-raised-to-75-by-dan-ives-amid-288-ytd-surge-analyst-calls-2025-a-primetime-year-for-ai">Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A &#8216;Primetime&#8217; Year For AI</a></strong></p>
<p>&#8220;The sale of our steelmaking coal business is another important step toward delivering the strategy we set out in May to create a world-class copper, premium iron ore, and crop nutrients business. We're focused on streamlining costs, simplifying our portfolio, and unlocking market value,&#8221; said Anglo American CEO <strong>Duncan Wanblad</strong>.</p>
<p>The company has set a target of $1 billion in cost savings by 2025 and expects an additional $800 million in recurring pre-tax benefits. The broader restructuring plan includes divesting from coal, platinum, nickel, and diamonds. The demerger of <strong>Anglo American Platinum</strong> (Amplats) is expected by mid-2025, and the nickel business sale is progressing with strong interest.</p>
<p>The crown jewel of Anglo American&#8217;s portfolio, <strong>De Beers</strong>, remains on books. Weaker Chinese diamond demand and an influx of synthetics have created persisting weakness, making asset sales unattractive.</p>
<p>Earlier this year, Anglo American embarked on a major restructuring to fend off a <a href="https://www.benzinga.com/news/large-cap/24/05/39068033/time-runs-out-for-bhp-deal-49-billion-acquisition-of-anglo-american-proves-too-complex-to-solve">takeover bid from <strong>BHP</strong></a>. To position itself for long-term growth, the company is focusing on high-margin, future-facing minerals like copper, quality iron ore, and crop nutrients.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/24/11/42135153/mexicos-increased-mining-royalties-could-deter-7-billion-in-foreign-investments"><strong>Mexico&#8217;s Increased Mining Royalties Could Deter $7 Billion In Foreign Investments</strong></a></li>
</ul>


Commodities

AAUKF

Anglo American Sells Coal Portfolio For $3.8 Billion

<p><a href="https://www.globenewswire.com/Tracker?data=WVHca8aAB5_CJSALiU4s_ywNZ4O0DYj6z-1DZbut8kG5sM32VITm6AVcm7fHueyWufVk-8cIr_O4JymiEBg1RZfrmDsEsit_V1Wgj3ShdKhr3RtHE6rkrhd4yTfZqPEL">Alignment Health Plan</a>, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced that members enrolled in its HMO plans in Maricopa County now have access to over 4,500 primary care providers, specialists and hospitals, including more than a dozen Banner Health hospitals, through its partnership with <a href="https://www.globenewswire.com/Tracker?data=tjKYqJ9X9SAtefAByAutg02SeZugWiyfjGjvd2HwdtQXW5WZNYREB_aGReugBw4uRrsGh95v49oxIWMQlayL0LoKDV2CFkT944DuLX9363z8DUUJyyAjg4f3o44iJaf9rdrU5vH5OQziyAdXw0OFkaDfzOpnFmQl1yeI8dp8k9o=">Arizona Priority Care, an affiliate of Heritage Provider Network</a>.</p>
<p>Arizona Priority Care first entered into an <a href="https://www.globenewswire.com/Tracker?data=d4CjNyxKb8IVRvJ2aBsxdr4RCUIBV-_SBcKCLCCb5_p1uSKDfYRmfgnXNAykP8HyAQ9kKgolft6gyKE_lYOicKzSkVU3aQBsCM4W0iouHYe4BopdNh3TGDSSFlCmYg4bzAOBZoQRNIQmIYp71_EFAHrCjFcgUEUexhsG2xQVUy5uE3qIaXrzW8k_TvnBy3vQreoi89cJDbDK7eyLr1SOejP2VuUkEnSdhofwY6YPuwE=">agreement</a> with Alignment when the MA plan debuted in the state in 2022. Through this relationship, Alignment Health Plan members will now have expanded access to Arizona Priority Care's network of providers and hospitals that serve Maricopa County.</p>


Biotech

General

ALHC

Alignment Health Plan Expands Access To Care In Arizona Through Enhanced Agreement With Arizona Priority Care

<p>Ambarella (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) is gearing up to announce its quarterly earnings on Tuesday, 2024-11-26. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Ambarella will report an <strong>earnings per share</strong> (EPS) of $0.04.</p>
<p>The market awaits Ambarella's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.06, which was followed by a 10.63% increase in the share price the next day.</p>
<p>Here's a look at Ambarella's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.19</td>
<td>-0.31</td>
<td>-0.33</td>
<td>-0.39</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.13</td>
<td>-0.26</td>
<td>-0.24</td>
<td>-0.28</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>11.0%</td>
<td>21.0%</td>
<td>0.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546938_0.png" alt="eps graph" /></p>
<h3>Market Performance of Ambarella's Stock</h3>
<p>Shares of Ambarella were trading at $63.62 as of November 22. Over the last 52-week period, shares are up 19.48%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Observations about Ambarella</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Ambarella.</p>
<p>The consensus rating for Ambarella is Buy, derived from 9 analyst ratings. An average one-year price target of $75.0 implies a potential 17.89% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Diodes, Synaptics and Silicon Laboratories, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Diodes is maintaining an Buy status according to analysts, with an average 1-year price target of $68.5, indicating a potential 7.67% upside.</li>
<li>Analysts currently favor an Buy trajectory for Synaptics, with an average 1-year price target of $101.75, suggesting a potential 59.93% upside.</li>
<li>The consensus outlook from analysts is an Neutral trajectory for Silicon Laboratories, with an average 1-year price target of $111.4, indicating a potential 75.1% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Diodes, Synaptics and Silicon Laboratories, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ambarella</td>
<td>Buy</td>
<td>2.58%</td>
<td>$38.74M</td>
<td>-6.33%</td>
</tr>
<tr>
<td>Diodes</td>
<td>Buy</td>
<td>-13.49%</td>
<td>$118.01M</td>
<td>0.77%</td>
</tr>
<tr>
<td>Synaptics</td>
<td>Buy</td>
<td>8.41%</td>
<td>$120.90M</td>
<td>-1.57%</td>
</tr>
<tr>
<td>Silicon Laboratories</td>
<td>Neutral</td>
<td>-18.34%</td>
<td>$90.31M</td>
<td>-2.62%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Ambarella is positioned at the top for Revenue Growth with 2.58%. It is at the bottom for Gross Profit with $38.74M. Ambarella is at the bottom for Return on Equity with -6.33%.</p>
<h3>All You Need to Know About Ambarella</h3>
<p>Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, and security cameras. Ambarella's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.</p>
<h3>Ambarella's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Ambarella displayed positive results in 3 months. As of 31 July, 2024, the company achieved a solid revenue growth rate of approximately <strong>2.58%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Ambarella's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-54.75%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Ambarella's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-6.33%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Ambarella's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-5.41%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Ambarella's debt-to-equity ratio is below the industry average at <strong>0.01</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/AMBA/earnings"><strong>To track all earnings releases for Ambarella visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

AMBA

A Look Ahead: Ambarella's Earnings Forecast

AVGO

Arrow Electronics Partners With Broadcom To Distribute VMware Solutions Across U.S. And Canada, Offering Full Cloud Portfolio Through ArrowSphere Platform To Enhance Channel Partner Opportunities

<p>3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) will release its quarterly earnings report on Tuesday, 2024-11-26. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate 3D Sys to report an <strong>earnings per share</strong> (EPS) of $-0.09.</p>
<p>The announcement from 3D Sys is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings Track Record</h3>
<p>In the previous earnings release, the company missed EPS by $0.10, leading to a 8.15% drop in the share price the following trading session.</p>
<p>Here's a look at 3D Sys's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.04</td>
<td>-0.08</td>
<td>-0.01</td>
<td>-0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.14</td>
<td>-0.17</td>
<td>-0.11</td>
<td>0.01</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-8.0%</td>
<td>3.0%</td>
<td>-23.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546929_0.png" alt="eps graph" /></p>
<h3>3D Sys Share Price Analysis</h3>
<p>Shares of 3D Sys were trading at $3.2 as of November 22. Over the last 52-week period, shares are down 39.48%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<h3>Analyst Insights on 3D Sys</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on 3D Sys.</p>
<p>With 3 analyst ratings, 3D Sys has a consensus rating of Buy. The average one-year price target is $3.25, indicating a potential 1.56% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of  and 3D Sys, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for  and 3D Sys, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>3D Sys</td>
<td>Buy</td>
<td>-11.66%</td>
<td>$47.10M</td>
<td>-6.90%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>3D Sys is at the bottom for Revenue Growth, with a decrease of 11.66%. It also ranks lowest for Gross Profit at $47.10M. Additionally, it has the lowest Return on Equity at -6.90%. Overall, 3D Sys is positioned at the bottom compared to its peers across all metrics.</p>
<h3>Discovering 3D Sys: A Closer Look</h3>
<p>3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.</p>
<h3>3D Sys: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Challenges:</strong> 3D Sys's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately <strong>-11.66%</strong>. This indicates a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> 3D Sys's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>-24.07%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> 3D Sys's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>-6.9%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> 3D Sys's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-3.25%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>0.72</strong>, caution is advised due to increased financial risk.</p>
<p><a href="https://www.benzinga.com/quote/DDD/earnings"><strong>To track all earnings releases for 3D Sys visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Look at 3D Sys's Upcoming Earnings Report

<p>Guess (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) is gearing up to announce its quarterly earnings on Tuesday, 2024-11-26. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Guess will report an <strong>earnings per share</strong> (EPS) of $0.37.</p>
<p>The announcement from Guess is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company missed EPS by $0.02, leading to a 1.43% increase in the share price the following trading session.</p>
<p>Here's a look at Guess's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.44</td>
<td>-0.40</td>
<td>1.56</td>
<td>0.62</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.42</td>
<td>-0.27</td>
<td>2.01</td>
<td>0.49</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>-1.0%</td>
<td>21.0%</td>
<td>-12.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546916_0.png" alt="eps graph" /></p>
<h3>Performance of Guess Shares</h3>
<p>Shares of Guess were trading at $17.07 as of November 22. Over the last 52-week period, shares are down 18.37%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Insights on Guess</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Guess.</p>
<p>With 11 analyst ratings, Guess has a consensus rating of Buy. The average one-year price target is $28.36, indicating a potential 66.14% upside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Shoe Carnival and Caleres, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Shoe Carnival received a Buy consensus from analysts, with an average 1-year price target of $51.0, implying a potential 198.77% upside.</li>
<li>The consensus outlook from analysts is an Neutral trajectory for Caleres, with an average 1-year price target of $37.5, indicating a potential 119.68% upside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Shoe Carnival and Caleres, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Guess</td>
<td>Buy</td>
<td>10.24%</td>
<td>$319.94M</td>
<td>-2.04%</td>
</tr>
<tr>
<td>Shoe Carnival</td>
<td>Buy</td>
<td>-7.76%</td>
<td>$119.94M</td>
<td>3.07%</td>
</tr>
<tr>
<td>Caleres</td>
<td>Neutral</td>
<td>-1.76%</td>
<td>$310.88M</td>
<td>4.91%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Guess is positioned in the middle among its peers for revenue growth, with a growth rate of 10.24%. It ranks at the bottom for gross profit at $319.94M. In terms of return on equity, Guess is at the bottom with a rate of -2.04%.</p>
<h3>Delving into Guess's Background</h3>
<p>Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.</p>
<h3>Guess: Delving into Financials</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Guess displayed positive results in 3 months. As of 31 July, 2024, the company achieved a solid revenue growth rate of approximately <strong>10.24%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Guess's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-1.47%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-2.04%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Guess's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-0.39%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> Guess's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>2.86</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<p><a href="https://www.benzinga.com/quote/GES/earnings"><strong>To track all earnings releases for Guess visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Look Ahead: Guess's Earnings Forecast

<p>Embecta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMBC#NASDAQ">EMBC</a>) is preparing to release its quarterly earnings on Tuesday, 2024-11-26. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Embecta to report an <strong>earnings per share</strong> (EPS) of $0.36.</p>
<p>The announcement from Embecta is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.28, which was followed by a 0.0% drop in the share price the next day.</p>
<p>Here's a look at Embecta's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.46</td>
<td>0.40</td>
<td>0.46</td>
<td>0.40</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.74</td>
<td>0.67</td>
<td>0.61</td>
<td>0.59</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>7.000000000000001%</td>
<td>1.0%</td>
<td>-8.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546902_0.png" alt="eps graph" /></p>
<h3>Tracking Embecta's Stock Performance</h3>
<p>Shares of Embecta were trading at $13.82 as of November 22. Over the last 52-week period, shares are down 19.65%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/EMBC/earnings"><strong>To track all earnings releases for Embecta visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


EMBC

Uncovering Potential: Embecta's Earnings Preview

<p>JOYY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YY#NASDAQ">YY</a>) is preparing to release its quarterly earnings on Tuesday, 2024-11-26. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect JOYY to report an <strong>earnings per share</strong> (EPS) of $0.94.</p>
<p>Investors in JOYY are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.28, leading to a 3.1% increase in the share price the following trading session.</p>
<p>Here's a look at JOYY's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.89</td>
<td>0.81</td>
<td>0.77</td>
<td>0.69</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.17</td>
<td>1.02</td>
<td>1.01</td>
<td>1.22</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>-4.0%</td>
<td>-6.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546895_0.png" alt="eps graph" /></p>
<h3>Performance of JOYY Shares</h3>
<p>Shares of JOYY were trading at $33.91 as of November 22. Over the last 52-week period, shares are down 11.86%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/YY/earnings"><strong>To track all earnings releases for JOYY visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What to Expect from JOYY's Earnings

<p>Titan Machinery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TITN#NASDAQ">TITN</a>) will release its quarterly earnings report on Tuesday, 2024-11-26. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Titan Machinery to report an <strong>earnings per share</strong> (EPS) of $0.02.</p>
<p>The market awaits Titan Machinery's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS missed by $0.02 in the last quarter, leading to a 6.11% increase in the share price on the following day.</p>
<p>Here's a look at Titan Machinery's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.19</td>
<td>0.64</td>
<td>1.02</td>
<td>1.53</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.17</td>
<td>0.41</td>
<td>1.05</td>
<td>1.32</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>6.0%</td>
<td>-6.0%</td>
<td>-6.0%</td>
<td>8.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546886_0.png" alt="eps graph" /></p>
<h3>Titan Machinery Share Price Analysis</h3>
<p>Shares of Titan Machinery were trading at $15.14 as of November 22. Over the last 52-week period, shares are down 38.3%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Insights Shared by Analysts on Titan Machinery</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Titan Machinery.</p>
<p>Titan Machinery has received a total of 3 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $21.67, the consensus suggests a potential 43.13% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Hudson Technologies, Alta Equipment Group and Lavoro, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>The consensus among analysts is an Neutral trajectory for Hudson Technologies, with an average 1-year price target of $7.55, indicating a potential 50.13% downside.</li>
<li>As per analysts' assessments, Alta Equipment Group is favoring an Neutral trajectory, with an average 1-year price target of $14.5, suggesting a potential 4.23% downside.</li>
<li>The consensus outlook from analysts is an Outperform trajectory for Lavoro, with an average 1-year price target of $7.0, indicating a potential 53.76% downside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary presents essential metrics for Hudson Technologies, Alta Equipment Group and Lavoro, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Titan Machinery</td>
<td>Neutral</td>
<td>-1.38%</td>
<td>$112.38M</td>
<td>-0.65%</td>
</tr>
<tr>
<td>Hudson Technologies</td>
<td>Neutral</td>
<td>-19.02%</td>
<td>$15.94M</td>
<td>3.11%</td>
</tr>
<tr>
<td>Alta Equipment Group</td>
<td>Neutral</td>
<td>-3.73%</td>
<td>$124.60M</td>
<td>-25.71%</td>
</tr>
<tr>
<td>Lavoro</td>
<td>Outperform</td>
<td>7.57%</td>
<td>$235.70M</td>
<td>-29.51%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Titan Machinery ranks in the middle among its peers for consensus rating. It is at the bottom for revenue growth and gross profit, while it is at the top for return on equity.</p>
<h3>Delving into Titan Machinery's Background</h3>
<p>Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.</p>
<h3>Titan Machinery: Financial Performance Dissected</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Titan Machinery's financials over 3 months reveals challenges. As of 31 July, 2024, the company experienced a decline of approximately <strong>-1.38%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Titan Machinery's net margin is impressive, surpassing industry averages. With a net margin of <strong>-0.68%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Titan Machinery's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>-0.65%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Titan Machinery's ROA excels beyond industry benchmarks, reaching <strong>-0.2%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Titan Machinery's debt-to-equity ratio surpasses industry norms, standing at <strong>2.03</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<p><a href="https://www.benzinga.com/quote/TITN/earnings"><strong>To track all earnings releases for Titan Machinery visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


TITN

A Preview Of Titan Machinery's Earnings

<p>L3Harris Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) has received an indefinite delivery, indefinite quantity award from the U.S. Navy, worth up to $999 million, to provide U.S. and coalition forces with resilient communications technology.</p>
<p>Over the next five years, L3Harris will deliver its Multifunctional Information Distribution System Joint Tactical Radio System Terminals (<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.l3harris.com%2Fall-capabilities%2Fmids-jtrs-software-programmable-radio&amp;esheet=54156884&amp;newsitemid=20241125575835&amp;lan=en-US&amp;anchor=MIDS+JTRS&amp;index=1&amp;md5=9c675d99aaf17966c6e78b44b0c8c3b9">MIDS JTRS</a>). L3Harris is one of two providers of the MIDS JTRS solution, which is a critical, software-defined Link 16 resilient communication radio for a variety of air, ground and maritime platforms.</p>


Contracts

L3Harris Technologies Receives An Indefinite Delivery, Indefinite Quantity Award From The U.S. Navy, Worth Up To $999M, To Provide U.S. And Coalition Forces With Resilient Communications Technology

<p>Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) is preparing to release its quarterly earnings on Tuesday, 2024-11-26. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Urban Outfitters to report an <strong>earnings per share</strong> (EPS) of $0.86.</p>
<p>Anticipation surrounds Urban Outfitters's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Historical Earnings Performance</h3>
<p>The company's EPS beat by $0.24 in the last quarter, leading to a 9.57% drop in the share price on the following day.</p>
<p>Here's a look at Urban Outfitters's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1</td>
<td>0.51</td>
<td>0.73</td>
<td>0.82</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.24</td>
<td>0.69</td>
<td>0.69</td>
<td>0.88</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-10.0%</td>
<td>-5.0%</td>
<td>-13.0%</td>
<td>-12.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546873_0.png" alt="eps graph" /></p>
<h3>Performance of Urban Outfitters Shares</h3>
<p>Shares of Urban Outfitters were trading at $38.98 as of November 22. Over the last 52-week period, shares are up 14.54%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Views on Urban Outfitters</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Urban Outfitters.</p>
<p>Urban Outfitters has received a total of 2 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $43.0, the consensus suggests a potential 10.31% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of American Eagle Outfitters, Boot Barn Holdings and Victoria's Secret, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for American Eagle Outfitters, with an average 1-year price target of $25.25, suggesting a potential 35.22% downside.</li>
<li>For Boot Barn Holdings, analysts project an Buy trajectory, with an average 1-year price target of $171.56, indicating a potential 340.12% upside.</li>
<li>Victoria's Secret is maintaining an Neutral status according to analysts, with an average 1-year price target of $27.38, indicating a potential 29.76% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for American Eagle Outfitters, Boot Barn Holdings and Victoria's Secret, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Urban Outfitters</td>
<td>Neutral</td>
<td>6.27%</td>
<td>$493.29M</td>
<td>5.34%</td>
</tr>
<tr>
<td>American Eagle Outfitters</td>
<td>Neutral</td>
<td>7.51%</td>
<td>$498.90M</td>
<td>4.48%</td>
</tr>
<tr>
<td>Boot Barn Holdings</td>
<td>Buy</td>
<td>13.71%</td>
<td>$152.86M</td>
<td>2.94%</td>
</tr>
<tr>
<td>Victoria's Secret</td>
<td>Neutral</td>
<td>-0.70%</td>
<td>$501M</td>
<td>7.15%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Urban Outfitters ranks in the middle among its peers for revenue growth. It is at the bottom for gross profit and return on equity.</p>
<h3>Discovering Urban Outfitters: A Closer Look</h3>
<p>Founded in 1970, Philadelphia-based Urban Outfitters is an apparel and home goods retailer that operates more than 700 stores and e-commerce in the United States (87.5% of fiscal 2024 sales) and other regions. Its retail nameplates are Urban Outfitters, Free People, FP Movement, and Anthropologie. Retail accounted for 91% of fiscal 2024 revenue, but the firm also sells products through a wholesale operation, owns some restaurants, and operates a clothing rental and resale business called Nuuly (5% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.</p>
<h3>Urban Outfitters's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Urban Outfitters showcased positive performance, achieving a revenue growth rate of <strong>6.27%</strong> as of 31 July, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Urban Outfitters's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>8.69%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>5.34%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Urban Outfitters's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>2.78%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Urban Outfitters's debt-to-equity ratio is below the industry average. With a ratio of <b>0.49</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/URBN/earnings"><strong>To track all earnings releases for Urban Outfitters visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


URBN

A Glimpse of Urban Outfitters's Earnings Potential

<p>Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) will release its quarterly earnings report on Tuesday, 2024-11-26. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Abercrombie &amp; Fitch to report an <strong>earnings per share</strong> (EPS) of $2.22.</p>
<p>The market awaits Abercrombie &amp; Fitch's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings History Snapshot</h3>
<p>The company's EPS beat by $0.28 in the last quarter, leading to a 2.83% increase in the share price on the following day.</p>
<p>Here's a look at Abercrombie &amp; Fitch's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.22</td>
<td>1.73</td>
<td>2.83</td>
<td>1.18</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.50</td>
<td>2.14</td>
<td>2.97</td>
<td>1.83</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>-6.0%</td>
<td>-5.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546864_0.png" alt="eps graph" /></p>
<h3>Tracking Abercrombie &amp; Fitch's Stock Performance</h3>
<p>Shares of Abercrombie &amp; Fitch were trading at $151.99 as of November 22. Over the last 52-week period, shares are up 101.36%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Insights on Abercrombie &amp; Fitch</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Abercrombie &amp; Fitch.</p>
<p>With 8 analyst ratings, Abercrombie &amp; Fitch has a consensus rating of Neutral. The average one-year price target is $185.62, indicating a potential 22.13% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Gap, Boot Barn Holdings and Urban Outfitters, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>The prevailing sentiment among analysts is an Neutral trajectory for Gap, with an average 1-year price target of $27.8, implying a potential 81.71% downside.</li>
<li>As per analysts' assessments, Boot Barn Holdings is favoring an Buy trajectory, with an average 1-year price target of $171.56, suggesting a potential 12.88% upside.</li>
<li>Urban Outfitters is maintaining an Neutral status according to analysts, with an average 1-year price target of $43.0, indicating a potential 71.71% downside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
<p>Within the peer analysis summary, vital metrics for Gap, Boot Barn Holdings and Urban Outfitters are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Abercrombie &amp; Fitch</td>
<td>Neutral</td>
<td>21.24%</td>
<td>$736.26M</td>
<td>11.65%</td>
</tr>
<tr>
<td>Gap</td>
<td>Neutral</td>
<td>2.93%</td>
<td>$1.58B</td>
<td>9.08%</td>
</tr>
<tr>
<td>Boot Barn Holdings</td>
<td>Buy</td>
<td>13.71%</td>
<td>$152.86M</td>
<td>2.94%</td>
</tr>
<tr>
<td>Urban Outfitters</td>
<td>Neutral</td>
<td>6.27%</td>
<td>$493.29M</td>
<td>5.34%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Abercrombie &amp; Fitch ranks highest in Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, it is at the bottom compared to its peers.</p>
<h3>Delving into Abercrombie &amp; Fitch's Background</h3>
<p>Abercrombie &amp; Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie &amp; Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.</p>
<h3>Financial Insights: Abercrombie &amp; Fitch</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Abercrombie &amp; Fitch displayed positive results in 3 months. As of 31 July, 2024, the company achieved a solid revenue growth rate of approximately <strong>21.24%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Abercrombie &amp; Fitch's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>11.74%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Abercrombie &amp; Fitch's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>11.65%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Abercrombie &amp; Fitch's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>4.42%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Abercrombie &amp; Fitch's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.74</strong>.</p>
<p><a href="https://www.benzinga.com/quote/ANF/earnings"><strong>To track all earnings releases for Abercrombie &amp; Fitch visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Abercrombie & Fitch's Earnings Outlook

<p><strong>Autodesk</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-11-26. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Autodesk will report an <strong>earnings per share</strong> (EPS) of $2.11. </p>
<p>The announcement from Autodesk is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings Track Record</h3>
<p>Last quarter the company beat EPS by $0.15, which was followed by a 0.07% increase in the share price the next day.</p>
<p>Here's a look at Autodesk's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2</td>
<td>1.77</td>
<td>1.95</td>
<td>1.99</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.15</td>
<td>1.87</td>
<td>2.09</td>
<td>2.07</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>0.0%</td>
<td>-3.0%</td>
<td>3.0%</td>
<td>-7.000000000000001%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546856_0.png" alt="eps graph" /></p>
<h3>Performance of Autodesk Shares</h3>
<p>Shares of Autodesk were trading at $321.27 as of November 22. Over the last 52-week period, shares are up 54.9%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Views on Autodesk</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Autodesk.</p>
<p>Analysts have provided Autodesk with 26 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $316.65, suggesting a potential 1.44% downside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Workday, Atlassian and Roper Techs, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Workday received a Buy consensus from analysts, with an average 1-year price target of $298.5, implying a potential 7.09% downside.</li>
<li>The consensus among analysts is an Outperform trajectory for Atlassian, with an average 1-year price target of $242.58, indicating a potential 24.49% downside.</li>
<li>The consensus outlook from analysts is an Buy trajectory for Roper Techs, with an average 1-year price target of $641.6, indicating a potential 99.71% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>The peer analysis summary presents essential metrics for Workday, Atlassian and Roper Techs, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Autodesk</td>
<td>Outperform</td>
<td>11.90%</td>
<td>$1.36B</td>
<td>12.17%</td>
</tr>
<tr>
<td>Workday</td>
<td>Buy</td>
<td>16.68%</td>
<td>$1.57B</td>
<td>1.60%</td>
</tr>
<tr>
<td>Atlassian</td>
<td>Outperform</td>
<td>21.48%</td>
<td>$970.16M</td>
<td>-12.01%</td>
</tr>
<tr>
<td>Roper Techs</td>
<td>Buy</td>
<td>12.87%</td>
<td>$1.22B</td>
<td>2.01%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Autodesk ranks at the top for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, Autodesk is at the top compared to its peers.</p>
<h3>About Autodesk</h3>
<p>Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction; product design and manufacturing; and media and entertainment. Autodesk software enables design, modeling, and rendering needs of these industries. The company has over 4 million paid subscribers across 180 countries.</p>
<h3>Breaking Down Autodesk's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Autodesk's revenue growth over a period of 3 months has been noteworthy. As of 31 July, 2024, the company achieved a revenue growth rate of approximately <strong>11.9%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.</p>
<p><strong>Net Margin:</strong> Autodesk's net margin excels beyond industry benchmarks, reaching <strong>18.74%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Autodesk's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>12.17%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Autodesk's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>2.85%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>1.05</strong>, caution is advised due to increased financial risk.</p>
<p><a href="https://www.benzinga.com/quote/ADSK/earnings"><strong>To track all earnings releases for Autodesk visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


ADSK

Insights Ahead: Autodesk's Quarterly Earnings

<p>During the last three months, 13 analysts shared their evaluations of WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for WR Berkley, revealing an average target of $65.15, a high estimate of $76.00, and a low estimate of $56.00. Surpassing the previous average price target of $62.09, the current average has increased by 4.93%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546855_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>The standing of WR Berkley among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Robert Cox</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$69.00</td>
<td>-</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$76.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$68.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$69.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$63.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$58.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>David Motemaden</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$60.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$68.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$67.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$73.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$63.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Yaron Kinar</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$57.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Underweight</td>
<td>$56.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to WR Berkley. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of WR Berkley compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of WR Berkley's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of WR Berkley's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/WRB/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on WR Berkley analyst ratings.</strong></a></p>
<h2>Delving into WR Berkley's Background</h2>
<p>W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.</p>
<h3>Financial Milestones: WR Berkley's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.</p>
<p><strong>Positive Revenue Trend:</strong> Examining WR Berkley's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>10.57%</strong> as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> WR Berkley's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>10.83%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>4.51%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> WR Berkley's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.92%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>0.34</strong>, WR Berkley faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings For WR Berkley

<p>Cannabis advisors and agents-in-charge at the Zen Leaf cannabis dispensary in Evanston, Illinois unanimously ratified their first collective bargaining agreement with Teamsters Local 777. Zen Leaf is a subsidiary of the multi-state operator <strong>Verano Holdings</strong> (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTCQX">VRNOF</a>).</p>
<p>"We successfully negotiated and ratified this collective bargaining agreement in less than three months, which is probably the fastest turnaround we've had for a first contract in this industry," stated <strong>Jim Glimco</strong>, president of Local 777. "We're organizing and winning contracts faster than ever before because everyone in this field recognizes we're a force to be reckoned with. Congratulations to all of the workers who stuck together to demand a contract with the same high standards we've secured for other multi-state cannabis operators in Illinois."</p>
<p><strong>Read Also: </strong><a href="https://www.benzinga.com/markets/cannabis/24/11/42067867/illinois-launches-cannabis-research-institute-with-7m-in-funding">Illinois Launches Cannabis Research Institute With $7M In Funding</a></p>
<p><em><strong>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</strong></em></p>
<p>The three-year contract includes a number of changes including more paid holidays, a minimum 14% wage increase over the lifetime of the agreement, due process during disciplinary matters, and a guarantee that a successor employer will assume the contract if another company buys the dispensary. Workers also receive retirement benefits, something that is only available to union members at the company.</p>
<p>"Cannabis workers are organizing and bargaining better contracts faster because they know a Teamsters contract brings stability to their jobs and respect from the industry for the work they do," said <strong>Jesse Case</strong>, Teamsters food processing division director.</p>
<p>The news comes after workers at <strong>PharmaCann</strong>, one of the largest vertically integrated cannabis companies in the U.S., <a href="https://www.benzinga.com/markets/cannabis/24/11/41887709/prices-up-50-wages-barely-moved-says-pharmacann-worker-and-new-teamster-member">joined Teamsters Local 337</a> following an overwhelming unionization vote at the company's Michigan facility.</p>
<p>In recent years, Teamsters have worked to unionize workers in the emerging cannabis industry. Efforts included <strong>the Cannabist Company (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CBSTF#OTCQX">CBSTF</a>) </strong>in <a href="https://www.benzinga.com/markets/cannabis/24/05/38669949/cannabis-workers-in-l-a-join-teamsters-to-improve-pay-working-conditions-and-have-a-voice" target="_blank" rel="noreferrer noopener">California</a>,<strong> Cresco Labs (OTCQX:</strong>CRLBF) in <a href="https://www.benzinga.com/markets/cannabis/24/05/38585820/teamsters-unionize-cannabis-workers-at-another-cresco-labs-dispensary-in-illinois-it-feels-good" target="_blank" rel="noreferrer noopener">Illinois</a>,<strong> Grassdoor </strong>in <a href="https://www.benzinga.com/markets/cannabis/23/03/31477358/workers-at-two-more-cannabis-companies-unionize-with-teamsters-and-ufcw" target="_blank" rel="noreferrer noopener">California</a>, <strong>Nabis</strong> in <a href="https://www.benzinga.com/markets/cannabis/24/05/38797830/84-cannabis-warehouse-workers-and-drivers-in-california-join-teamsters-for-contracts-reflecting-">California</a> and<strong> Verano Holdings in</strong><a href="https://www.benzinga.com/markets/cannabis/22/08/28566870/veranos-firing-of-union-supporters-flops-zen-leaf-chicago-workers-join-teamsters-local-777" target="_blank" rel="noreferrer noopener">Chicago</a>.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cannabis/24/10/41176622/teamsters-added-50-000-new-members-in-less-than-3-years-partly-due-to-cannabis-industry-growth">Teamsters Added 50,000 New Members In Less Than 3 Years, Partly Due To Cannabis Industry Growth</a></strong></li>
</ul>
<p><em>Photo: Benzinga edit with images by lexandros Michailidisand Oleksandrum via Shutterstock</em></p>


Cannabis

THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC.

CBSTF

VRNOF

More Paid Holidays For Cannabis Workers At Zen Leaf Dispensary Through Agreement With Teamsters

<p>In the latest quarter, 10 analysts provided ratings for Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $39.9, a high estimate of $44.00, and a low estimate of $35.00. Witnessing a positive shift, the current average has risen by 3.8% from the previous average price target of $38.44.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546848_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Ncino. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$44.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Robert Trout</td>
<td>Macquarie</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Terry Tillman</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$44.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Alexander Sklar</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Outperform</td>
<td>$38.00</td>
<td>-</td>
</tr>
<tr>
<td>Robert Trout</td>
<td>Macquarie</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Aaron Kimson</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$43.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Terry Tillman</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$37.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Charles Nabhan</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$40.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$38.00</td>
<td>$38.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Ncino. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Ncino compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Ncino's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Ncino's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NCNO/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Ncino analyst ratings.</strong></a></p>
<h2>All You Need to Know About Ncino</h2>
<p>Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes &amp; workflow and utilizes data analytics &amp; artificial intelligence that enables financial institutions to onboard new clients, make loans and manage the entire loan life cycle, open deposits, and other accounts and manage regulatory compliance. It also offers professional services, including configuration &amp; implementation, training, and advisory services. Ncino generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.</p>
<h3>Ncino: Delving into Financials</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Ncino showcased positive performance, achieving a revenue growth rate of <strong>12.94%</strong> as of 31 July, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Ncino's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-8.34%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>-1.03%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Ncino's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>-0.78%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Ncino's debt-to-equity ratio is below the industry average. With a ratio of <b>0.1</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


NCNO

The Analyst Landscape: 10 Takes On Ncino

<p>Manchester United (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) is preparing to release its quarterly earnings on Tuesday, 2024-11-26. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Manchester United to report an <strong>earnings per share</strong> (EPS) of $-0.28.</p>
<p>The market awaits Manchester United's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company missed EPS by $0.03, which was followed by a 0.83% increase in the share price the next day.</p>
<p>Here's a look at Manchester United's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.17</td>
<td>-0.27</td>
<td>-0.22</td>
<td>-0.060</td>
<td>-0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.20</td>
<td>-0.31</td>
<td>0.15</td>
<td>-0.067</td>
<td>-0.08</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>0.0%</td>
<td>2.0%</td>
<td>1.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732546847_0.png" alt="eps graph" /></p>
<h3>Performance of Manchester United Shares</h3>
<p>Shares of Manchester United were trading at $17.5 as of November 22. Over the last 52-week period, shares are down 10.38%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MANU/earnings"><strong>To track all earnings releases for Manchester United visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MANU

An Overview of Manchester United's Earnings

Analyst Laura Chico from Wedbush maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) and increased the price target to $48.00...

Positive Outlook for Viridian Therapeutics Driven by Promising VRDN-008 Data and Strategic Expansion

In a report released today, Serge Belanger from Needham maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report), with a price tar...

Viridian Therapeutics: Buy Rating Backed by Promising THRIVE-2 Trial Results and Strategic Initiatives

Viridian Therapeutics, Inc. ( ($VRDN) ) has released its Q3 earnings. Here is a breakdown of the information Viridian Therapeutics, Inc. presented ...

Viridian Therapeutics Reports Increased Cash Reserves Amid Losses

H.C. Wainwright raised the firm's price target on Viridian Therapeutics (VRDN) to $34 from $27 and keeps a Buy rating on the shares. The firm expec...

Viridian Therapeutics price target raised to $34 from $27 at H.C. Wainwright

H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price target of $34....

Viridian Therapeutics: Promising Developments and Strategic Initiatives Drive Buy Rating

Leerink Partners analyst Thomas Smith reiterated a Buy rating on Viridian Therapeutics (VRDN – Research Report) on November 12 and set a price targ...

Viridian Therapeutics: Promising FcRn Inhibitor Developments and Strong Buy Recommendation

Viridian Therapeutics ($VRDN) has captured investors' attention with recent breakthroughs in developing effective treatments for severe and rare di...

Viridian Therapeutics (VRDN) Has Captured Investors' Attention with Recent Breakthroughs

Viridian Therapeutics (VRDN) has received a new Buy rating, initiated by TD Cowen analyst, Joseph Thome. Joseph Thome has given his Buy rating due ...

Viridian Therapeutics: Buy Rating Due to Promising TED Therapy and Market Potential

TD Cowen initiated coverage of Viridian Therapeutics (VRDN) with a Buy rating and no price target The company's lead asset veligrotug is an anti-IG...

Viridian Therapeutics initiated with a Buy at TD Cowen

Needham analyst Serge Belanger maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price target of $38.00. Se...

Buy Rating Reaffirmed for Viridian Therapeutics Ahead of Promising THRIVE-2 Trial Results

AMGN

VRDN

Press Releases

Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2024 Financial Results

Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024

Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease

Comments

Viridian Therapeutics

Vendite allo scoperto

Viridian Therapeutics (NASDAQ:VRDN) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO